Article
Extracranial rhabdoid tumours: what we have learned so far and future directions.
The Lancet. Oncology - 1 Jul 2013
Brennan Bernadette, Stiller Charles, Bourdeaut Franck
Abstract excerpt
Extracranial rhabdoid tumours are rare, and often occur in infants. Although the kidney is the most common site, they can occur anywhere in the body. Most contain a biallelic inactivating mutation in SMARCB1, which is part of the chromatin remodelling complex SWI/SNF, and functions as a classic tumour suppressor gene. Despite multimodal therapy, outcome in rhabdoid tumours remains poor with only 31% of patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
